Albumin human

Albumin human is filed as Plasma volume expander. The sections below restate public label fields stored for this profile.

Class
Plasma volume expander
Route
INTRAVENOUS
Dosage forms
Risk of transmission of infectious agents ( 5.1 ). Caution where hypervolemia and its consequences or hemodilution could represent a special risk ( 5.2 ) Do not dilute with water for injection ( 5.2 )
Manufacturer
BPL

Approved uses

KEDBUMIN ® is a 25% albumin solution indicated for: Hypovolemia ( 1.1 ) and Hypoalbuminemia ( 1.2 ) Prevention of central volume depletion after paracentesis due to cirrhotic ascites ( 1.3 ) Ovarian hyperstimulation syndrome (OHSS) ( 1.4 ) Adult Respiratory Distress Syndrome (ARDS) ( 1.5 ) Burns ( 1.6 ) Hemodialysis patients undergoing long term dialysis ( 1.7 ) Patients who cannot tolerate substantial volumes of salt solution ( 1.7 ) Priming as part of a cardiopulmonary bypass fluids ( 1.8 )

How it works

Human albumin is not a glycoprotein. It has the lowest molecular weight (66,241 Daltons) of all plasma proteins. Because of its three dimensional structure, solutions of albumin have a lower viscosity than solutions of other plasma proteins. This is important since work performed by the heart depends in part on the viscosity of blood. Human albumin accounts quantitatively for more than half of the total proteins in the circulation (by weight) and represents approximately 10 % of the protein synthesized in the liver. Approximately 40% of albumin is contained in the circulation. The remainder is located in the extravascular space of tissues, principally muscle, skin, and intestine. KEDBUMIN ® 25% has a hyperoncotic effect. A major function of albumin is its role in osmotic regulation. Albumin is responsible for 75% of normal oncotic pressure within the intravascular space [13, 14]. Other physiological functions include binding and transport of molecules (hormones, enzymes, drugs and toxins); free radical scavenging; hemostatic effects (platelet function inhibition and antithrombotic effects); and capillary membrane permeability [14].

Warnings and precautions

17 PATIENT COUNSELING INFORMATION Ensure that patients to be treated with ALBUMINEX 25% are informed of the potential risks and benefits of its use for their clinical condition [see Warnings and Precautions (5) ] . Check that they are not known to be allergic to the product or its excipients [see Contraindications (4) and Description (11) ] . Make them aware of the symptoms of anaphylaxis [see Hypersensitivity (5.1) ]. Make them aware of the symptoms of potential circulatory overload [see Hypervolemia (5.2) Inform patients that because ALBUMINEX 25% is derived from human blood plasma it may contain infectious agents that cause disease (e.g. viruses and, theoretically CJD agent) although the risk of infection from ALBUMINEX 25% has been reduced by the procedures used in donor selection and during manufacture [see Infectious Diseases (5.6) and Description (11) ] .

Contraindications

KEDBUMIN ® is contraindicated in patients with a history of hypersensitivity to albumin, excipients used in its formulation, or components of the container [11]. KEDBUMIN ® is also contraindicated in severely anemic patients and in patients with heart failure.

Common side effects

Rigors (Common); Hypotension/decreased bp (Common); Tachycardia/increased heart rate (Common); Pyrexia (Common); Feeling cold (Common); Nausea (Common); Vomiting (Common); Dyspnea/bronchospasm (Common)

Adverse reactions

The most common adverse reactions include fever, chills, rash, nausea, vomiting, tachycardia, and hypotension ( 6 ). To report SUSPECTED ADVERSE REACTIONS, contact Kedrion Biopharma, Inc. at 1-855-3KDRION (1-855-353-7466) or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch

Dosage and administration

Intravenous Administration Only.

Drug interactions

KEDBUMIN ® should not be mixed with other medicinal products including blood and blood components, but can be administered concomitantly with other parenterals such as whole blood, plasma, saline, glucose or sodium lactate when medically necessary. KEDBUMIN ® should not be mixed with protein hydrolysates or solutions containing alcohol since these combinations may cause protein precipitation.

Common questions

What is Albumin human approved to treat?

According to its FDA label, Albumin human is approved for: KEDBUMIN ® is a 25% albumin solution indicated for: Hypovolemia ( 1.1 ) and Hypoalbuminemia ( 1.2 ) Prevention of central volume depletion after paracentesis due to cirrhotic ascites ( 1.3 ) Ovarian hyperstimulation syndrome (OHSS) ( 1.4 ) Adult Respiratory Distress Syndrome (ARD… For medical advice, please talk to your prescriber or pharmacist.

What class of drug is Albumin human?

Albumin human belongs to the Plasma volume expander class of medications.

What form does Albumin human come in?

The FDA label lists Albumin human as: Risk of transmission of infectious agents ( 5.1 ). Caution where hypervolemia and its consequences or hemodilution could represent a special risk ( 5.2 ) Do not dilute with water for injection ( 5.2 ); intravenous route. Available strengths and packaging vary by manufacturer.

Does Albumin human have a Boxed Warning?

Our ingest of the FDA label for Albumin human does not include a Boxed Warning at this time. See the full label on DailyMed for the current, authoritative version.

Is Albumin human currently under recall?

The FDA Enforcement Report does not show an active/ongoing recall for Albumin human in our latest ingest. Recall data can change daily — verify at FDA.gov.

Who makes Albumin human?

The FDA label lists BPL as a labeler/manufacturer of Albumin human. Multiple firms may market generics of the same molecule.

How should Albumin human be stored?

The FDA label states: "KEDBUMIN ® is supplied as a sterile, aqueous solution for single dose intravenous administration containing 0.25 g per mL human albumin. It is available in the following glass vial size: 50 mL vial 25% (NDC 76179-025-01)…" Follow the packaging insert for the authoritative guidance.

On this site

Related medications in this class or category

Loading full data from Know Your Drugs Institute…